Department of Medicine 4 – Nephrology and Hypertension

A PHD inhibitor prevents changes in the phosphoproteome and capillary rarefaction by CsA: treatment option for CKD? (2022) Schley G, Goppelt-Strübe M Journal article Twenty-Four Month Results in Patients With Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial (2022) Bloch M, Kirtane A, Mahfoud F, Azizi M, Basile J, Daemen J, Saxena M, et al. Conference contribution Influence of Gender on Blood Pressure Reduction After Renal Denervation in GSR DEFINE (2022) Weil J, Mahfoud F, Schmieder R, Narkiewicz K, Williams B, Fahy M, Mancia G Conference contribution Prevalence of hereditary tubulointerstitial kidney diseases in the German Chronic Kidney Disease study (2022) Popp B, Ekici AB, Knaup K, Schneider K, Uebe S, Park J, Bafna V, et al. Journal article Comparison of physician and artificial intelligence-based symptom checker diagnostic accuracy (2022) Gräf M, Knitza J, Leipe J, Krusche M, Welcker M, Kuhn S, Mucke J, et al. Journal article Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry (2022) Schmieder R, Mahfoud F, Mancia G, Narkiewicz K, Ruilope L, Hutton D, Cao K, et al. Journal article A Symptom Checker App Is Better at Classifying Inflammatory Disease Than Physicians Who Are Presented Identical Information (2022) Gräf M, Knitza J, Leipe J, Krusche M, Welcker M, Kuhn S, Mucke J, et al. Conference contribution Treatment effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in people underrepresented from the ontarget trial: Analysis of routinely collected data using trial replication methods (2022) Baptiste PJ, Wong A, Schultze A, Cunnington M, Mann J, Clase C, Leyrat C, et al. Conference contribution Dysregulation of the polyamine system in favour of its catabolism is a common mechanism after kidney injury (2022) Sieckmann T, Ogel N, Kelterborn S, Boivin F, Schley G, Fahling M, Ashraf MI, et al. Conference contribution Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial (2022) Saritas T, Reinartz S, Krueger T, Ketteler M, Liangos O, Labriola L, Stenvinkel P, et al. Journal article